Immunovant, Inc.
IMVT
$25.75
$0.110.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 165.43% | 10.35% | 6.95% | 12.37% | -45.77% |
| Total Receivables | -26.12% | 5.01% | -19.90% | -54.37% | 116.13% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 31.26% | 52.68% | 91.23% | 105.53% | 89.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 152.81% | 13.04% | 10.65% | 15.30% | -41.96% |
|
|
|||||
| Total Current Assets | 152.81% | 13.04% | 10.65% | 15.30% | -41.96% |
| Net Property, Plant & Equipment | -31.40% | -11.73% | 16.80% | 58.32% | 15.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.13% | 15.25% | -- | -- | -- |
| Total Assets | 150.01% | 13.04% | 12.17% | 16.49% | -40.83% |
|
|
|||||
| Total Accounts Payable | -56.52% | -66.63% | -28.93% | 146.76% | 406.80% |
| Total Accrued Expenses | 18.91% | 21.33% | 30.31% | 22.88% | 73.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -28.99% | -92.48% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 1,720.00% | -- |
| Total Other Current Liabilities | -- | -- | -- | 1,720.00% | -- |
| Total Current Liabilities | -3.01% | -5.10% | 17.51% | 41.49% | 112.81% |
|
|
|||||
| Total Current Liabilities | -3.01% | -5.10% | 17.51% | 41.49% | 112.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.01% | -5.10% | 17.51% | 41.49% | 112.81% |
|
|
|||||
| Common Stock & APIC | 74.10% | 36.47% | 35.12% | 34.96% | 3.70% |
| Retained Earnings | -40.97% | -45.47% | -49.00% | -50.12% | -51.00% |
| Treasury Stock & Other | -51.71% | -24.08% | -4.56% | -23.53% | 513.17% |
| Total Common Equity | 179.66% | 15.73% | 11.73% | 14.52% | -48.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 179.66% | 15.73% | 11.73% | 14.52% | -48.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 179.66% | 15.73% | 11.73% | 14.52% | -48.09% |
|
|
|||||